| Description |
| Product Type |
Product Size |
| Tablet |
100'S |
| Product Company |
| GSK/td>
|
Co Trimoxazole 800/160mg (Sulfamethoxazole+ Trimethoprim) |
| Product Type |
Product Size |
| Tablet |
6'S |
| Product Company |
| GSK |
Co- amoxiclav 625mg |
| Product Type |
Product Size |
| Tablet |
5'S |
| Product Company |
| Getz Pharma |
Moxifloxacin 400mg |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Bosch Pharmaceuticals |
Tazobactum + Piperacillin 4.5g, 2.5g |
| Product Type |
Product Size |
| Capsules |
5'S |
| Product Company |
| Sami Pharmaceutical |
Cefixime Trihydrate 400mg |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
AJM Pharmaceuticals |
|
| Content | Co-trimoxazole is a combination of trimethoprim and sulfamethoxazole and is in a class of medications called sulfonamides. It works by stopping the growth of bacteria.
| Amoxicillin/clavulanic acid, also known as co-amoxiclav or amox-clav, sold under the brand name Augmentin, among others, is an antibiotic medication used for the treatment of a number of bacterial infections. | Moxifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infections. Antibiotics such as moxifloxacin will not work for colds, flu, or other viral infections. | Tazobactum is a beta lactamase inhibitor administered with antibiotics such as piperacilin to prevent their degradation resulting in increased efficacy. | Cefixime, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime. Cefixime is highly stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to cefixime. | Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. |
Reviews
There are no reviews yet.